Alexander KarpAlexander Karp earned $1B in 2024

In 2024, Robert A. Bradway earned $2.58M in total compensation at Amgen, primarily from $1.87M salary. Most recently acquired 11,988 shares in May 2024. Currently holds stock worth $171.35M. Has donated $63.30M in stock to charitable causes. Has led Amgen for over 13 years.

Compensation History

Annual executive compensation data for Robert A. Bradway, including salary, bonuses, and stock awards.

Year

2024

Total Compensation

$2.58M

Salary

$1.87M

Bonus

$0.00

Other

$714.33K

Salary

$1.87M

Board Justification

Our executive compensation program is designed to achieve the following objectives: •Pay for performance in a manner that strongly aligns with stockholder interests by rewarding both our short- and long-term performance. •Drive our business strategy by positioning our staff to execute on our strategic priorities in the near- and longer-term with a mix of incentives and targets (financial and operational) that are tied to near- and long-term performance periods and activities. •Attract, motivate, and retain the highest level of talent by providing competitive compensation, consistent with their roles and responsibilities, our success, and their contributions to this success. •Mitigate compensation risk by maintaining pay practices that reward actions and outcomes consistent with the sound operation of our Company and with the creation of long-term stockholder value. •Consider all Amgen staff members in the design of our executive compensation program to ensure a consistent approach that encourages and rewards all staff members who contribute to our success.

Bonus

$0.00

Board Justification

N/A

Other Compensation

$714.33K

Board Justification

Other expenses include: (a)Company contributions to non-profit charities designated by the executive in the amount of $10,000 for Messrs. Bradway, Gordon, and Griffith; (b)Executive physicals; and (c)Personal transportation costs for Dr. Bradner related to travel between his home in Massachusetts and the Company's Thousand Oaks headquarters per his offer letter by commercial aircraft or via chartered aircraft using a service agreement with a private aviation provider we were required to assume in connection with our acquisition of Horizon Therapeutics plc (now known as Horizon Therapeutics Limited) and based on actual amounts charged for these flights as well as related ground transportation and lodging costs.

Restricted Stock

$0.000 N/A

Board Justification

N/A

Performance Metrics

•Non-GAAP earnings per share (EPS)•Non-GAAP return on invested capital (ROIC)•Total shareholder return (TSR) relative to that of the S&P 500•Revenues •Non-GAAP net income•Pipeline, clinical study, and regulatory goals•Sustainability and integration goals

A

Robert A. Bradway

CEO of Amgen

Education

Bachelor's degree in Economics from Amherst College and an MBA from the Wharton School of the University of Pennsylvania.

Field of Expertise

Finance & Banking - Finance

Sector of Economy

Healthcare

Born

July 19, 1962 - 63 years ago

CEO of Amgen for

13 years 6 months (May 2012 - Present)

Previous Experience

Executive Vice President and Chief Financial Officer at Amgen

Holdings

Track Robert A. Bradway's stock holdings and portfolio value over time.

Total Stock Sold

$6.32M

AMGN

$6.32M

42,000 AMGN shares

What if they kept their stock?

If Robert A. Bradway didn't sell their stock, today they would have:
Extra AMGN42,000 shares worth $14.29M.
This is 126.23% and $7.98M more than what they got when they sold the stock.

Charitable Transactions

AMGN

186,000 shares

AMGN

Recent Charitable Transactions

AMGN

186,000 shares

AMGN

Dec 2, 2024

Charity

Insider Trading

Robert A. Bradway's recent stock transactions, purchases, and sales filed with the SEC.

AMGN

186,000 shares

AMGN

Dec 2, 2024

Charity

AMGN

90,000 shares

AMGN

Dec 2, 2024

Charity

AMGN

11,988 shares

AMGN

May 7, 2024

Received

AMGN

41,133 shares

AMGN

Mar 6, 2024

Received

AMGN

13,486 shares

AMGN

May 2, 2023

Received

AMGN

27,915 shares

AMGN

Mar 6, 2023

Received

AMGN

13,781 shares

AMGN

May 2, 2022

Received

AMGN

34,964 shares

AMGN

Mar 1, 2022

Received

AMGN

13,280 shares

AMGN

Apr 30, 2021

Received

AMGN

38,953 shares

AMGN

Mar 2, 2021

Received

Rivals

Compare Robert A. Bradway with competitor CEOs and industry peers.